Articles published by IAVI

IAVI Awarded $36 Million From BARDA for Bundibugyo Virus Vaccine Development

October 28, 2026

From IAVI

Via ACCESS Newswire

IAVI Announces First Vaccinations at Liberia Site in Phase I Clinical Trial of Lassa Fever Vaccine Candidate

August 31, 2022

From IAVI

Via Business Wire

IAVI Welcomes Marion F. Gruber as Vice President, Public Health and Regulatory Science

January 18, 2022

From IAVI

Via Business Wire

IAVI and the Biomedical Advanced Research and Development Authority Partner to Advance Filovirus Vaccine Candidates

October 27, 2021

From IAVI

Via Business Wire

Spanish pharmaceutical company Zendal and IAVI partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials

July 14, 2021

From IAVI

Via Business Wire

EDCTP and CEPI Funding Moves IAVI's Lassa fever Vaccine Candidate Into Advanced Clinical Development

June 15, 2021

From IAVI

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.